Synektik

Synektik EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Synektik (SNT.WA) as of Oct 31, 2026 is 16.13. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 23.69 — a change of -31.89% (lower).

EV/EBIT

16.13

YoY

-31.89%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Synektik is 2025 16.13 . EV/EBIT (Enterprise Value to EBIT) of Synektik was 2024 23.69 . It decreases by -31.89% lower compared to the previous year.

The Synektik EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
199.22 PLN
Jan 1, 2020
210.54 PLN
Jan 1, 2021
226.43 PLN
Jan 1, 2022
359.88 PLN
Jan 1, 2023
37.33 PLN
Jan 1, 2024
23.69 PLN
Jan 1, 2025
16.13 PLN
Jan 1, 2026 (e)
9.34 PLN
The Synektik EV/EBIT history
YEAREV/EBITYoY
est9.34-42.10%
16.13-31.89%
23.69-36.54%
37.33-89.63%
359.88+58.93%
226.43+7.55%
210.54+5.68%
199.22-8.52%
217.79-69.27%
708.66-40.47%
1,190.35-126.75%
-4,450.19-1,048.60%
469.13+2,844.97%
15.93-104.86%
-328.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Synektik's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Synektik's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Synektik's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Synektik grows earnings faster than its peers.

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

EV/EBIT (Enterprise Value to EBIT) of Synektik is 16.13 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Synektik changed from 23.69 to 16.13, representing a -31.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Synektik since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Synektik with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Synektik

All Key Metrics — Synektik